Surfactante pulmonar: posible intervención frente al nuevo Síndrome Respiratorio Agudo Severo Coronavirus 2 (SARS-CoV-2)

Díaz-Casañas, Elaine; Rodríguez-Moya, Valentín Santiago; Montes de Oca Martínez, Nivian.
Rev. habanera cienc. méd ; 19(supl.1): e3361, 2020.
Artículo en Español | LILACS, CUMED | ID: biblio-1126920

Documentos relacionados

  1. Favipiravir and the Need for Early Ambulatory Treatment of SARS-CoV-2 Infection (COVID-19).
  2. SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic.
  3. SARS-CoV: Lessons learned; opportunities missed for SARS-CoV-2.
  4. COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?
  5. Can data from paediatric cohorts solve the COVID-19 puzzle?
  6. Nucleoside Analogs and Nucleoside Precursors as Drugs in the Fight against SARS-CoV-2 and Other Coronaviruses.
  7. Efficacy and safety of current therapeutic options for COVID-19 - lessons to be learnt from SARS and MERS epidemic: A systematic review and meta-analysis.
  8. SARS-CoV2 RNA detection in a pancreatic pseudocyst sample.
  9. Modeling Potential Autophagy Pathways in COVID-19 and Sarcoidosis.
  10. Systemic administration of glucocorticoids, cardiovascular complications and mortality in patients hospitalised with COVID-19, SARS, MERS or influenza: A systematic review and meta-analysis of randomised trials.